Cömert Melda - Ege University Faculty of Medicine, Department of Hematology, İzmir, Turkey.

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 87 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience

Ebru Kilic Gunes,Sureyya Yigit Kaya, Fatih Yaman, Mustafa Kemal Yeniay, Kurtulus Vural,Melda Comert, Omur Gokmen Sevindik,Neslihan Andic, Simten Dagdas, Ilknur Nizam Ozen,Leylagul Kaynar,Filiz Yavasoglu,

LEUKEMIA RESEARCH (2024): 107484-107484

Cited0Views0WOSBibtex

Comparison of Infectious Complications in Patients Receiving High-Dose Cyclophosphamide as GvHD Prophylaxis After Transplantation From A 9/10 HLA-Matched Unrelated Donor with Standard GvHD Prophylaxis After Transplant From A Fully Matched Related Donor

Selim Sayýn, Murat Yýldýrým,Melda Cömert,Bilge Uğur,Esra Şafak Yýlmaz,Ferit Avcu,Ali Uğur Ural,Meltem Aylı

Mediterranean Journal of Hematology and Infectious Diseasesno. 1 (2024): e2024016-e2024016

Cited0Views0WOSBibtex

Comparison of Infectious Complications in Patients Receiving High-Dose Cyclophosphamide as GvHD Prophylaxis After Transplantation From A 9/10 HLAMatched Unrelated Donor with Standard GvHD Prophylaxis After Transplant From A Fully Matched Related Donor

Selim Sayin,Murat Yildirim,Melda Comert,Bilge Ugur,Esra Safak Yilmaz,Ferit Avcu,Ali Ugur Ural,Meltem Ayli

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASESno. 1 (2024)

Cited0Views0Bibtex

Gilteritinib (xospata ®) in turkey: early access program results

Mehmet Hilmi DOGU,Ali Irfan Emre TEKGUNDUZ,Burak DEVECI,Gulten KORKMAZ,Melda COMERT,Omur Gokmen SEVINDIK,Osman Yokuş,İstemi Serin

Mediterranean Journal of Hematology and Infectious Diseasesno. 1 (2023): e2023031-e2023031

Cited0Views0Bibtex

Real-life data of azacitidine-venetoclax combination in acute myeloid leukemia patients: a single center experience

Tuba Bulduk,Melda Cömert, Ebru KILIÇ,Selim Sayın,Murat Yıldırım,Meltem Aylı

DergiPark (Istanbul University) (2023)

Cited0Views0Bibtex

Gilteritinib (XOSPATA (R)) in Turkey: Early Access Program Results

Mehmet Hilmi Dogu,Ali Irfan Emre Tekgunduz,Burak Deveci,Gulten Korkmaz,Melda Comert,Omur Gokmen Sevindik,Osman Yokus,Istemi Serin

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASESno. 1 (2023)

Cited0Views0WOSBibtex

Pb1897: gilteritinib in turkey: early access program results

Mehmet Hilmi Doğu,Ali İrfan Emre Tekgündüz,Burak Devecı,Gülten Korkmaz,Melda Cömert,Ömür Gökmen Sevindik,Osman Yokuş,İstemi Serin

HemaSphereno. S3 (2023): e4210211-e4210211

Cited0Views0Bibtex

POSTER: MDS-143 Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

İbrahim Halil Açar,Figen Atalay,Esra Terzi Demirsoy,Ferda Can,Zeynep Tuğba Güven,Mustafa Çetiner,Anıl Tombak,Melda Cömert,Birol Güvenç

Clinical Lymphoma, Myeloma & Leukemia (2023): S180-S354

Cited0Views0Bibtex

Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

Ibrahim Halil Acar,Figen Atalay,Esra Terzi Demirsoy,Ferda Can,Zeynep Tugba Guven,Mustafa Cetiner,Anil Tombak,Melda Comert,Birol Guvenc

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S354-S354

Cited0Views0Bibtex

Pleural Effusion Secondary to Actinomyces Infection as a Late Complication of Laparoscopic Cholecystectomy

Melda Cömert,Soner Gürsoy,Mahmut Töbü

semanticscholar（2022）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn